FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100526350> ?p ?o ?g. }

• W3100526350 endingPage "304" @default.
• W3100526350 startingPage "299" @default.
• W3100526350 abstract "Neuroendocrine carcinoma of the cervix (NEC) is a rare and highly aggressive cervical malignancy. Given that no targeted therapy has been approved specifically to NEC, we investigated the presence of novel, potentially targetable biomarkers in a large cohort of NEC. Sixty-two NEC were molecularly profiled for biomarkers of targeted therapies including antibody-drug conjugates [delta-like canonical notch ligand 3 (DLL3), a trophoblast cell surface antigen 2 (TROP-2), and folate receptor 1 (FOLR1)], NTRK1-3 gene fusions, and immune checkpoint inhibitors [programmed death-ligand 1 (PD-L1), tumor mutational burden, and microsatellite instability] using immunohistochemistry and DNA/RNA next-generation sequencing assays. A cohort of squamous cell carcinomas of the cervix (n=599) was used for comparison for immune-oncology biomarkers. DLL3 expression was observed in 81% of the cases. DLL3 expression was inversely correlated with commonly observed pathogenic mutations in PIK3CA (17%) (P=0.018) and PTEN (10%) (P=0.006). Other more frequently seen pathogenic mutations (TP53 17%, KRAS 11%, and CTNNB1 5%) were not associated with DLL3 expression. TROP-2 expression was detected in only 1 case and no case expressed FOLR1. Although NTRK protein expression was observed in 21% of the cases, none of these had an NTRK gene fusion. PD-L1 expression (10%) and high tumor mutational burden (3%) were significantly less frequent in NEC compared with the squamous cell carcinoma cohort (79% and 11%, respectively). None of the NEC exhibited high microsatellite instability status. Despite frequent DLL3 expression in NEC, a potential therapeutic benefit of DLL3-targeted drugs remains uncertain given the recent failure of the Rova-T therapeutic trial in small cell lung carcinomas. Small cohorts of NEC enriched in PIK3CA/PTEN/AKT and programmed cell death protein 1/PD-L1 alterations indicate therapeutic roles for their respective inhibitors." @default.
• W3100526350 created "2020-11-23" @default.
• W3100526350 creator A5037644603 @default.
• W3100526350 creator A5051355838 @default.
• W3100526350 creator A5056904750 @default.
• W3100526350 creator A5062208753 @default.
• W3100526350 creator A5069485497 @default.
• W3100526350 creator A5079388843 @default.
• W3100526350 date "2020-11-17" @default.
• W3100526350 modified "2023-10-18" @default.
• W3100526350 title "Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix" @default.
• W3100526350 cites W1527088201 @default.
• W3100526350 cites W1940241680 @default.
• W3100526350 cites W1993348958 @default.
• W3100526350 cites W2049553585 @default.
• W3100526350 cites W2082996894 @default.
• W3100526350 cites W2289712604 @default.
• W3100526350 cites W2339403964 @default.
• W3100526350 cites W2518951780 @default.
• W3100526350 cites W2568427436 @default.
• W3100526350 cites W2583304018 @default.
• W3100526350 cites W2617066209 @default.
• W3100526350 cites W2767948052 @default.
• W3100526350 cites W2773976262 @default.
• W3100526350 cites W2788157633 @default.
• W3100526350 cites W2789288884 @default.
• W3100526350 cites W2790164909 @default.
• W3100526350 cites W2790201099 @default.
• W3100526350 cites W2791150369 @default.
• W3100526350 cites W2799468356 @default.
• W3100526350 cites W2888845108 @default.
• W3100526350 cites W2891825311 @default.
• W3100526350 cites W2899710937 @default.
• W3100526350 cites W2900090367 @default.
• W3100526350 cites W2909679049 @default.
• W3100526350 cites W2923057410 @default.
• W3100526350 cites W2938145015 @default.
• W3100526350 cites W2941150576 @default.
• W3100526350 cites W2953495640 @default.
• W3100526350 cites W2960676092 @default.
• W3100526350 cites W2972769810 @default.
• W3100526350 cites W2973098277 @default.
• W3100526350 cites W2980727210 @default.
• W3100526350 cites W2982411421 @default.
• W3100526350 cites W3001363261 @default.
• W3100526350 cites W3007542404 @default.
• W3100526350 cites W3015552022 @default.
• W3100526350 cites W3021941122 @default.
• W3100526350 doi "https://doi.org/10.1097/pai.0000000000000884" @default.
• W3100526350 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8132903" @default.
• W3100526350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33208671" @default.
• W3100526350 hasPublicationYear "2020" @default.
• W3100526350 type Work @default.
• W3100526350 sameAs 3100526350 @default.
• W3100526350 citedByCount "15" @default.
• W3100526350 countsByYear W31005263502021 @default.
• W3100526350 countsByYear W31005263502022 @default.
• W3100526350 countsByYear W31005263502023 @default.
• W3100526350 crossrefType "journal-article" @default.
• W3100526350 hasAuthorship W3100526350A5037644603 @default.
• W3100526350 hasAuthorship W3100526350A5051355838 @default.
• W3100526350 hasAuthorship W3100526350A5056904750 @default.
• W3100526350 hasAuthorship W3100526350A5062208753 @default.
• W3100526350 hasAuthorship W3100526350A5069485497 @default.
• W3100526350 hasAuthorship W3100526350A5079388843 @default.
• W3100526350 hasBestOaLocation W31005263501 @default.
• W3100526350 hasConcept C104317684 @default.
• W3100526350 hasConcept C121608353 @default.
• W3100526350 hasConcept C126322002 @default.
• W3100526350 hasConcept C143998085 @default.
• W3100526350 hasConcept C180754005 @default.
• W3100526350 hasConcept C204232928 @default.
• W3100526350 hasConcept C2777740455 @default.
• W3100526350 hasConcept C2779399171 @default.
• W3100526350 hasConcept C2779767149 @default.
• W3100526350 hasConcept C2781187634 @default.
• W3100526350 hasConcept C2781230642 @default.
• W3100526350 hasConcept C502942594 @default.
• W3100526350 hasConcept C526805850 @default.
• W3100526350 hasConcept C55493867 @default.
• W3100526350 hasConcept C61320498 @default.
• W3100526350 hasConcept C71924100 @default.
• W3100526350 hasConcept C86803240 @default.
• W3100526350 hasConceptScore W3100526350C104317684 @default.
• W3100526350 hasConceptScore W3100526350C121608353 @default.
• W3100526350 hasConceptScore W3100526350C126322002 @default.
• W3100526350 hasConceptScore W3100526350C143998085 @default.
• W3100526350 hasConceptScore W3100526350C180754005 @default.
• W3100526350 hasConceptScore W3100526350C204232928 @default.
• W3100526350 hasConceptScore W3100526350C2777740455 @default.
• W3100526350 hasConceptScore W3100526350C2779399171 @default.
• W3100526350 hasConceptScore W3100526350C2779767149 @default.
• W3100526350 hasConceptScore W3100526350C2781187634 @default.
• W3100526350 hasConceptScore W3100526350C2781230642 @default.
• W3100526350 hasConceptScore W3100526350C502942594 @default.
• W3100526350 hasConceptScore W3100526350C526805850 @default.
• W3100526350 hasConceptScore W3100526350C55493867 @default.
• W3100526350 hasConceptScore W3100526350C61320498 @default.

• next